Kiniksa Pharmaceuticals International (KNSA) Revenue (2021 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Revenue came in at $243.6 million in Q2 2026, up 55.36% YoY from $156.8 million in Q2 2025, and up 13.69% on a QoQ basis from $214.3 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Revenue (2021 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 6 years of Revenue data on file, last reported at $243.6 million in Q2 2026.
- Quarterly Revenue rose 55.36% year-over-year to $243.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $840.8 million (up 58.85% YoY) and the FY2025 annual result came in at $677.6 million, up 60.09% from the prior year.
- Revenue grew to $243.6 million in Q2 2026, from $214.3 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $243.6 million in Q2 2026 to a low of -$148.3 million in Q4 2022.
- A 5-year average of $102.2 million and a median of $103.9 million in 2022 frame the typical range for Revenue.
- The widest YoY moves for Revenue: up 719.64% in 2022, down 891.12% in 2022.
- Tracing KNSA's Revenue over 5 years: stood at -$148.3 million in 2022, then surged by 156.24% to $83.4 million in 2023, then jumped by 46.93% to $122.5 million in 2024, then surged by 64.95% to $202.1 million in 2025, then climbed by 20.52% to $243.6 million in 2026.
- The last three Revenue figures came in at $243.6 million (Q2 2026), $214.3 million (Q1 2026), and $202.1 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Kiniksa Pharmaceuticals International | 6.09 Bn | 5.57 Bn | 220.03 Mn | 243.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 243.60 Mn |
| Mar 31, 2026 | 214.27 Mn |
| Dec 31, 2025 | 202.13 Mn |
| Sep 30, 2025 | 180.86 Mn |
| Jun 30, 2025 | 156.80 Mn |
| Mar 31, 2025 | 137.79 Mn |
| Dec 31, 2024 | 122.54 Mn |
| Sep 30, 2024 | 112.21 Mn |
| Jun 30, 2024 | 108.63 Mn |
| Mar 31, 2024 | 79.86 Mn |
| Dec 31, 2023 | 83.40 Mn |
| Sep 30, 2023 | 67.05 Mn |
| Jun 30, 2023 | 71.47 Mn |
| Mar 31, 2023 | 48.35 Mn |
| Dec 31, 2022 | -148.30 Mn |
| Sep 30, 2022 | 99.14 Mn |
| Jun 30, 2022 | 26.97 Mn |
| Mar 31, 2022 | 32.19 Mn |
| Dec 31, 2021 | 18.75 Mn |
| Sep 30, 2021 | 12.10 Mn |